Stocks/ALT

Create a free account to see ACCE Scores

Sign up for free to unlock scores, score breakdowns, and stock analysis.

ALT

↓ PDF (Pro)
Altimmune Inc. Common Stock
HealthcareBiotechnologyUnited StatesNASDAQ
$3.04
+0.66%today
MKT CAP
$621M
-6.7% · 1Y
Earnings History
+23.9%
+15.8%
+21.0%
-11.2%
Q1 '25
Q2 '25
Q3 '25
Q4 '25
Analyst Targets
Current price
$3.04
Low
$2.50
Analyst Mean
$18.15
High
$28.00
10 analystsBuy
Full Financials
Trailing P/E-
Forward P/E-2.3x
EV/EBITDA-
Price/Sales-
Dividend Yield-
Revenue Growth YoY-
Earnings Growth YoY-
Revenue Growth QoQ+420.0%
5y Revenue CAGR-
5y Earnings CAGR-
Gross Margin-
Operating Margin-
Net Margin-
ROE-
Debt / Equity-
Free Cash Flow-
Insider Ownership0.4%
Institutional Ownership45.1%
Short % of Float22.13%
Days to Cover9.4d
1 Week+10.1%
1 Month-
3 Months-
6 Months-
YTD-
1 Year-
3 Years-
5 Years-
vs 50-day SMA-
vs 200-day SMA-
vs 52w High-
vs 52w Low-
Insider Transactions
FilerRoleTypeSharesPriceValueDate
GILL JOHN MDirectorBuy9,200$3.41$0.03M2026-04-06
WEAVER GREGORY LChief Financial OfficerBuy10,000$3.15$0.03M2026-04-01
DURSO JEROME BENEDICTChief Executive OfficerBuy15,000$3.14$0.05M2026-04-01
WEAVER GREGORY LChief Financial OfficerBuy5,000$3.54$0.02M2026-03-06
DURSO JEROME BENEDICTChief Executive OfficerBuy20,000$3.54$0.07M2026-03-06
Top Holders
HolderType% HeldValueΔ SharesAs of
Blackrock Inc.institution7.46%$0.03B+52.27%2025-12-31
Vanguard Group Incinstitution7.29%$0.03B+48.91%2025-12-31
State Street Corporationinstitution3.94%$0.02B+42.16%2025-12-31
SPDR SERIES TRUST-State Street SPDR S&P Biotech ETFfund3.50%$0.01B+39.79%2026-03-31
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fundfund2.52%$0.01B+20.27%2025-12-31
iShares Trust-iShares Russell 2000 ETFfund2.40%$0.01B+46.36%2026-03-31
Nuveen, LLCinstitution1.79%$0.01B+87.64%2026-03-31
Geode Capital Management, LLCinstitution1.76%$0.01B+13.63%2025-12-31
Tang Capital Management, LLCinstitution1.64%$0.01B+0.00%2025-12-31
Jane Street Group, LLCinstitution1.37%$0.01B+536.67%2025-12-31
VANGUARD HORIZON FUNDS-Vanguard Strategic Equity Fundfund1.21%$0.00B+58.22%2025-12-31
TIAA-CREF Funds-Nuveen Quant Small Cap Equity Fundfund1.11%$0.00B+100.00%2026-01-31
Morgan Stanleyinstitution1.05%$0.00B-8.80%2025-12-31
Susquehanna International Group, LLPinstitution1.05%$0.00B-0.38%2025-12-31
Goldman Sachs Group Incinstitution1.04%$0.00B+139.98%2025-12-31
VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fundfund0.88%$0.00B+23.40%2025-12-31
iShares Trust-iShares Russell 2000 Growth ETFfund0.82%$0.00B+43.70%2026-03-31
Vanguard Explorer Fundfund0.77%$0.00B+412.89%2026-01-31
iShares Trust-iShares Biotechnology ETFfund0.71%$0.00B-0.55%2026-03-31
Fidelity Salem Street Trust-Fidelity Small Cap Index Fundfund0.66%$0.00B-1.12%2026-01-31
TickerCapScoreP/EFwd P/EEV/EBITDAROEGrossD/EDiv
PTGX
Protagonist Therapeutics Inc. Common Stock
$6.6B5------0.00%
CELC
Celcuity Inc. Common Stock
$6.7B5------0.00%
ACLX
Arcellx Inc. Common Stock
$6.7B5-------
KYMR
Kymera Therapeutics Inc. Common Stock
$7.0B-----27.1%0%5.230.00%
TECH
Bio-Techne Corp Common Stock
$7.1B3672.724.4----63.00%
HALO
Halozyme Therapeutics Inc. Common Stock
$7.9B7325.56.6----0.00%
Peers selected by sector + industry + nearest market cap. Best in column highlighted green, worst red.
Unlock Full Financials
Growth metrics, valuation multiples, and profitability ratios on Starter+.
Upgrade from $15/mo →
Growth73Value58Quality82Momentum61Total5
Score breakdown on Starter+
Upgrade →
Score History (90d)
Pro onlyUpgrade →
Updated 5/8/2026
Recent Alerts
No alerts yet for ALT.
Want deep analysis?
This stock isn't in the ACCE researched universe. Browse 300+ stocks with full thesis, scores, and financial models.
Browse ACCE Indices →
Get the ACCE weekly digest
Index returns, picks recap, score movers - every Sunday. No fluff.